Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Res Social Adm Pharm. 2012 Oct 10;9(6):10.1016/j.sapharm.2012.09.003. doi: 10.1016/j.sapharm.2012.09.003

Table 2.

Numbers and proportions of individuals across racial and ethnic groups that would be eligible for MTM services in 1996–1997 according to 2008 eligibility criteria.

Analyses Number of Part D Drugs Number of Chronic Conditions Groups Number Eligible Number Eligible Weighted Proportion Eligible (%)
Main Analysis ≥ 5 ≥ 3 Whites 218 2,213,487 3.53
Blacks 39 249,685 3.52
Hispanics 29 133,588 3.42
Sensitivity Analysis 1 ≥ 5 ≥ 2 Whites 203 1,970,807 3.14
Blacks 33 198,880 2.80
Hispanics 26 122,380 3.14
Sensitivity Analysis 2 ≥ 5 ≥ 5 Whites 129 1,280,298 2.04
Blacks 17 117,679 1.66
Hispanics 18 95,640 2.45
Sensitivity Analysis 3 ≥ 2 ≥ 3 Whites 209 2,056,866 3.28
Blacks 33 198,880 2.80
Hispanics 26 122,380 3.14
Sensitivity Analysis 4 ≥ 2 ≥ 2 Whites 231 2,382,206 3.80
Blacks 39 249,685 3.52
Hispanics 29 133,588 3.42
Sensitivity Analysis 5 ≥ 2 ≥ 5 Whites 131 1,315,030 2.10
Blacks 17 117,679 1.66
Hispanics 18 95,640 2.45
Sensitivity Analysis 6 ≥ 15 ≥ 3 Whites 83 762,634 1.22
Blacks 6 51,811 0.73
Hispanics 11 42,941 1.10
Sensitivity Analysis 7 ≥ 15 ≥ 2 Whites 86 838,846 1.34
Blacks 8 58,165 0.82
Hispanics 13 50,250 1.29
Sensitivity Analysis 8 ≥ 15 ≥ 5 Whites 62 566,763 0.90
Blacks 5 49,514 0.70
Hispanics 9 34,934 0.90

Note: Whites: non-Hispanic whites; Blacks: non-Hispanic blacks; total Part D drugs costs ≥ 4,000 in 2006 dollar for all analyses.

P > 0.05 when comparing Whites to Blacks and Whites to Hispanics based on all analyses.